NEW YORK (GenomeWeb) – Bionano Genomics on Wednesday lowered the size of its proposed IPO, according to a filing with the US Securities and Exchange Commission.

The San Diego-based genomic research tools company plans to offer 2,450,000 units, each consisting of one share of common stock and one warrant to purchase a share of common stock, at a price of $6.00 to $7.00 per unit.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Reuters reports that UK researchers are using gene-editing tools to develop flu-resistant chickens.

Nature calls for genomics to become part of the World Health Organization's cholera surveillance approach.

Vox explores a proposal to institute a lottery system to award grant funds.

In Genome Biology this week: gut microbiome study of individuals from Tanzania and Botswana, sixth version of the Network of Cancer Genes database, and more.